Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

Critical Care Medicine

Volumn 32, Issue 3, 2004, Pages 858-873

  Dellinger, R Phillip ^a   Carlet, Jean M ^b   Masur, Henry ^b   Gerlach, Herwig ^b   Calandra, Thierry ^b   Cohen, Jonathan ^b   Gea Banacloche, Juan ^b   Keh, Didier ^b   Marshall, John C ^b   Parker, Margaret M ^b   Ramsay, Graham ^b   Zimmerman, Janice L ^b   Vincent, Jean Louis ^b   Levy, Mitchell M ^b  

^a Camden NJ   (United States)

^b NONE

Author keywords

Evidence based medicine; Guidelines; Infection; Sepsis; Sepsis syndrome; Septic shock; Severe sepsis; Surviving Sepsis Campaign

Indexed keywords

ANTIBIOTIC AGENT; BICARBONATE; CORTICOSTEROID; DOBUTAMINE; DOPAMINE; ERYTHROPOIETIN; FRESH FROZEN PLASMA; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCORTISONE; INOTROPIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; NORADRENALIN; RECOMBINANT PROTEIN; STEROID; SUCRALFATE; VASOPRESSIN;

ACIDEMIA; ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ANEMIA; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CLINICAL EXAMINATION; CLINICAL PROTOCOL; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; ELECTRONICS; FLUID THERAPY; GLUCOSE BLOOD LEVEL; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HEALTH PROMOTION; HEART DISEASE; HEMODYNAMIC MONITORING; HIGH RISK POPULATION; HUMAN; HYPOGLYCEMIA; HYPOTENSION; INFECTION RISK; INTENSIVE CARE; INTUBATION; LUNG INJURY; MICROBIOLOGY; OXYGEN THERAPY; PERFUSION; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RESUSCITATION; REVIEW; SEDATION; SEPSIS; SEPTIC SHOCK; STRESS ULCER; SURVIVAL; TELECOMMUNICATION; VASCULAR RESISTANCE;

ADULT; AGE FACTORS; ALGORITHMS; CHILD; EVIDENCE-BASED MEDICINE; HUMANS; SEPSIS; SHOCK, SEPTIC;

EID: 3242775982     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000117317.18092.E4     Document Type: Review

References (135)

1. Dellinger RP: Cardiovascular management of septic shock. Crit Care Med 2003; 31: 946-955
2. Friedman G, Silva E, Vincent JL: Has the mortality of septic shock changed with time? Crit Care Med 1998; 26:2078-2086
3. Sackett DL: Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989; 95:2S-4S
4. Sprung CL, Bernard GR, Dellinger RP: Introduction. Intensive Care Med 2001; 27(Suppl):S1-S2
5. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
6. Weinstein MP, Relier LP, Murphy JR, et al: The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 1983; 5:35-53
7. Blot F, Schmidt E, Nitenberg G, et al: Earlier positivity of central venous versus peripheral blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 1998; 36:105-109
8. Mermel LA, Maki DG: Detection of bacteremia in adults: Consequences of culturing an inadequate volume of blood. Ann Intern Med 1993; 119:270-272
9. McCabe WR, Jackson GG: Gram negative bacteremia. Arch Intern Med 1962; 110: 92-100
10. Kreger BE, Craven DE, McCabe WR: Gram negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980; 68344-355
11. Leibovici L, Shraga I, Drucker M, et al: The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244:379-386
12. Ibrahim EH, Sherman G, Ward S, et al: The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-155
13. Hatala R, Dinh T, Cook DJ: Once-daily aminoglycoside dosing in immunocompetent adults: A meta-analysis. Ann Intern Med 1996; 124:717-725
14. Ali MZ, Goetz MB: A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997; 24: 796-809
15. Amsden GW, Ballow CH, Bertino JS: Pharniacokinetics and Pharmacodynamcis of Anti-infective Agents. In: Principles and Practice of Infectious Diseases. Fifth Edition. Mandell GL, Bennett JE, Dolin R (Eds). Philadelphia, Churchill Livingstone, 2000, pp 253-261
16. Hyatt JM, McKinnon PS, Zimmer GS, et al: The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcomes. Focus on antibacterial agents. Clin Pharmacokinet 1995; 28:143-160
17. Jimenez MF, Marshall JC: Source control in the management of sepsis. Intensive Care Med 2001; 27:S49-S62
18. Bufalari A, Giustozzi G, Moggi L: Postoperative intraabdominal abscesses: Percutaneous versus surgical treatment. Acta Chir Belg 1996; 96:197-200
19. Moss RL, Musemeche CA, Kosloske AM: Necrotizing fascitis in children: Prompt recognition and aggressive therapy improve survival. J Pediatr Surg 1996; 31:1142-1146
20. Centers for Disease Control and Prevention: Guidelines for the Prevention of Intravascular Catheter-Related Infections. MMWR 2002; 51:1-29
21. O'Grady NP, Alexander M, Dellinger EP, et al: Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2002; 35:1281-1307
22. Choi PTL, Yip G, Quinonez LG, et al: Crystalloids vs. colloids in fluid resuscitation: A systematic review. Crit Care Med 1999; 27: 200-210
23. Cook D, Guyatt G: Colloid use for fluid resuscitation: Evidence and spin. Ann Intern Med 2001; 135:205-208
24. Schierhout G, Roberts I: Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: A systematic review of randomized trials. BMJ 1998; 316:961-964
25. Hollenberg SM, Ahrens TS, Astiz ME, et al: Practice parameters for hemodynamic support of sepsis in adult patients. Crit Care Med 1999; 27:639-660
26. LeDoux D, Astiz ME, Carpati CM, et al: Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000; 28:2729-2732
27. Regnier B, Rapin M, Gory G, et al: Haemodynamic effects of dopamine in septic shock. Intensive Care Med 1977; 3:47-53
28. Martin C, Papazian L, Perrin G, et al: Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993; 103:1826-1831
29. Martin C, Viviand X, Leone M, et al: Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28:2758-2765
30. De Backer D, Creteur J, Silva E, et al: Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: Which is best? Crit Care Med 2003; 31:1659-1667
31. Bellomo R, Chapman M, Finfer S, et al: Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000; 356: 2139-2143
32. Kellum J, Decker J: Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med 2001; 29:1526-1531
33. Sharshar T, Blanchard A, Paillard M, et al: Circulating vasopressin levels in septic shock. Crit Care Med 2003; 31:1752-1758
34. Holmes CL, Patel BM, Russell JA, et al: Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120: 989-1002
35. Malay MB, Ashton RC, Landry DW, et al: Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999; 47:699-705
36. Holmes CL, Walley KR, Chittock DR, et al: The effects of vasopressin on hemodynamics and renal function in severe septic shock: A case series. Intensive Care Med 2001; 27:1416-1421
37. Gattinoni L, Brazzi L, Pelosi P, et al: A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995; 333:1025-1032
38. Hayes MA, Timmins AC, Yau EHS, et al: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330:1717-1722
39. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
40. Briegel J, Forst H, Haller M, et al: Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732
41. Bollaert PE, Charpentier C, Levy B, et al: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26:645-650
42. Annane D, Sebille V, Troche G, et al: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283: 1038-1045
43. Annane D, Cavaillon JM: Corticosteroids in sepsis: From bench to bedside? Shock 2003; 20:197-207
44. Marik PE, Zaloga GP: Adrenal insufficiency during septic shock. Crit Care Med 2003; 31:141-145
45. Cooper MS, Stewart PM: Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003; 348:727-734
46. Keh D, Boehnke T, Weber-Carstens S, et al: Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: A double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003; 167:512-520
47. Bone RC, Fisher CJ, Clemmer TP: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 317:653-658
48. Cronin L, Cook DJ, Carlet J, et al: Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature. Crit Care Med 1995; 23:1430-1439
49. The Veterans Administration Systemic Sepsis Cooperative Study Group: Effect on high-dose glucocorticoid therapy on mortality in patients with clinical signs of sepsis. N Engl J Med 1987; 317:659-665
50. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
51. Hébert PC, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled clinical trial of transfusion in critical care. N Engl J Med 1999; 340:409-417
52. Marik PE, Sibbald WJ: Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993; 269:3024-3029
53. Lorente JA, Landín L, De Pablo R, et al: Effects of blood transfusion on oxygen transport variables in severe sepsis. Crit Care Med 1993; 21:1312-1318
54. Corwin HL, Gettinger A, Rodriguez RM, et al: Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized double-blind, placebo-controlled trial. Crit Care Med 1999; 27:2346-2350
55. Corwin HL, Gettinger A, Pearl RG, et al: Efficacy of recombinant human erythropoietin in critically ill patients. JAMA 2002; 288:2827-2835
56. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists. JAMA 1994; 271:777-781
57. Guidelines for red blood cell and plasma transfusion for adults and children. Report of the Working Group. CMAJ 1997; 156(Suppl):S1-S24
58. Practice guidelines for blood component therapy. A report by the American Society of Anaesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996; 84:732-747
59. Warren BL, Eid A, Singer P, et al: High-dose antithrombin III in severe sepsis. A randomized controlled trial. JAMA 2001; 286: 1869-1878
60. Amato MB, Barbas CS, Medeiros DM, et al: Effect of a protective- ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338:347-354
61. Stewart TE, Meade MO, Cook DJ, et al: Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure-and Volume-Limited Ventilation Strategy Group. N Engl J Med 1998; 338: 355-361
62. Brochard L, Roudat-Thoraval F, Roupie E, et al: Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trial Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med 1998; 158:1831-1838
63. Brower RG, Shanholtz CB, Fessler HE, et al: Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 1999; 27:1492-1498
64. Brower RG, Fessier HE: Mechanical ventilation in acute lung injury and acute respiratory distress syndrome. Clin Chest Med 2000; 21:491-510
65. Eichacker PQ, Gerstenberger EP, Banks SM, et al: Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 2002; 166:1510-1514
66. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342:1301-1308
67. Hickling KG, Walsh J, Henderson S, et al: Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: A prospective study. Crit Care Med 1994; 22:1568-1578
68. Bidani A, Tzouanakis AE, Cardenas VJ, et al: Permissive hypercapnia in acute respiratory failure. JAMA 272:957-962
69. Marini JJ, Ravenscraft SA: Mean airway pressure: Physiologic determinants and clinical importance - Part I: Physiologic determinants and measurements. Crit Care Med 1992; 20:1461-1472
70. Gattinoni L, Marcolin R, Caspani ML, et al: Constant mean airway pressure with different patterns of positive pressure breathing during the adult respiratory distress syndrome. Bull Eur Physiopathol Respir 1985; 21:275-279
71. Pesenti A, Marcolin R, Prato P, et al: Mean airway pressure vs. positive end-expiratory pressure during mechanical ventilation. Crit Care Med 1985; 13:34-37
72. Stocker R, Neff T, Stein S, et al: Prone positioning and low-volume pressure-limited ventilation improve survival in patients with severe ARDS. Chest 1997; 111: 1008-1017
73. Lamm WJ, Graham MM, Albert RK: Mechanism by which prone position improves oxygenation in acute lung injury. Am J Respir Crit Care Med 1994; 150:184-193
74. Jolliet P, Bulpa P, Chevrolet JC: Effects of the prone position on gas exchange and hemodynamics in severe acute respiratory distress syndrome. Crit Care Med 1998; 26: 1977-1985
75. Gattinoni L, Tognoni G, Pesenti A, et al: Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 2001; 345:568-573
76. Chatte G, Sab JM, Dubois JM, et al: Prone position in mechanically ventilated patients with severe acute respiratory failure. Am J Respir Crit Care Med 1997; 155:473-478
77. Drakulovic M, Torres A, Bauer T, et al: Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: A randomised trial. Lancet 1999; 354:1851-1858
78. Esteban A, Alia I, Tobin MJ, et al: Effect of spontaneous breathing trial duration on outcome of attempts to discontinue mechanical ventilation. Spanish Lung Failure Collaborative Group. Am J Respir Crit Care Med 1999; 159:512-518
79. Ely EW, Baker AM, Dunagan DP, et al: Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 1996; 335:1864-1869
80. Esteban A, Alia I, Gordo F, et al: Extubation outcome after spontaneous breathing trials with T-tube or pressure support ventilation. The Spanish Lung Failure Collaborative Group. Am J Respir Crit Care Med 1997; 156:459-465
81. Kollef MH, Levy NT, Ahrens TS, et al: The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest 1998; 114:541-548
82. Kress JP, Pohlman AS, O'Connor MF, et al: Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342: 1471-1477
83. Brook AD, Ahrens TS, Schaiff R, et al: Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999; 27:2609-2615
84. Giostra E, Magistris MR, Pizzolato G, et al: Neuromuscular disorder in intensive care unit patients treated with pancuronium bromide. Occurrence in a cluster group of seven patients and two sporadic cases, with electrophysiologic and histologic examination. Chest 1994; 106:210-220
85. Rossiter A, Souney PF, McGowan S, et al: Pancuronium-induced prolonged neuromuscular blockade. Crit Care Med 1991; 19:1583-1587
86. Partridge BL, Abrams JH, Bazemore C, et al: Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. Crit Care Med 1990; 18:1177-1179
87. Vanderheyden BA, Reynolds HN, Gerold KB, et al: Prolonged paralysis after long-term vecuronium infusion. Crit Care Med 1992; 20:304-307
88. Meyer KC, Prielipp RC, Grossman JE, et al: Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 1994; 78:772-774
89. Manthous CA, Chatila W: Prolonged weakness after withdrawal of atracurium. Am J Respir Crit Care Med 1994; 150:1441-1443
90. Prielipp RC, Coursin DB, Scuderi PE, et al: Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg 1995; 81:3-12
91. Brandom BW, Yellon FF, Lloyd ME, et al: Recovery from doxacurium infusion administered to produce immobility for more than four days in pediatric patients in the intensive care unit. Anesth Analg 1997; 34: 307-314
92. Rudis MI, Sikora CA, Angus E, et al: A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med 1997; 25:25575-25583
93. Frankel H, Jeng J, Tilly E, et al: The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit. Am Surg 1996; 62: 503-506
94. van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367
95. Finney SJ, Zekveld C, Elia A, et al: Glucose control and mortality in critically ill patients. JAMA 2003; 2041-2047
96. Van den Berghe G, Wouters PJ, Bouillon R, et al: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31:359-366
97. Klein S, Kinney J, Jeejeebhoy K, et al: Nutrition support in clinical practice: Review of published data and recommendations for future research directions. A summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr 1997; 66:683-706
98. Mehta RL, McDonald B, Gabbai FB, et al: A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001; 60:1154-1163
99. Kellum J, Angus DC, Johnson JP, et al: Continuous versus intermittent renal replacement therapy: A meta-analysis. Intensive Care Med 2002; 28:29-37
100. Cooper DJ, Walley KR, Wiggs BR, et al: Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: A prospective, controlled clinical study. Ann Intern Med 1990; 112: 492-498
101. Mathieu D, Neviere R, Billard V, et al: Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: A prospective, controlled clinical study. Crit Care Med 1991; 19:1352-1356
102. Cade JF: High risk of the critically ill for venous thromboembolism. Crit Care Med 1982; 10:448-450
103. Belch JJ, Lowe GD, Ward AG, et al: Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J 1981; 26:115-117
104. Samama MM, Cohen AT, Darmon JY, et al: A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800
105. Borrero E, Bank S, Margolis I, et al: Comparison of antacid and sucralfate in the prevention of gastrointestinal bleeding in patients who are critically ill. Am J Med 1985; 79:62-64
106. Bresalier RS, Grendell JH, Cello JP, et al: Sucralfate versus titrated antacid for the prevention of acute stress-related gastrointestinal hemorrhage in critically ill patients. Am J Med 1987; 83:110-116
107. Cook D, Guyatt G, Marshall J, et al: A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 1998; 338:791-797
108. Stothert JC, Simonowitz DA, Dellinger EP, et al: Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill. Ann Surg 1980; 192: 169-174
109. Pollard AJ, Britto J, Nadel S, et al: Emergency management of meningococcal disease. Arch Dis Child 1999; 80:290-296
110. Kanter RK, Zimmerman JJ, Strauss RH, et al: Pediatric emergency intravenous access. Evaluation of a protocol. Am J Dis Child 1986; 140:132-134
111. Ngo NT, Cao XT, Kneen R, et al: Acute management of dengue shock syndrome: A randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis 2001; 32:204-213
112. Carcillo JA, Davis AL, Zaritsky A: Role of early fluid resuscitation in pediatric septic shock. JAMA 1991; 266:1242-1245
113. Powell KR, Sugarman LI, Eskenazi AE, et al: Normalization of plasma arginine vasopressin concentrations when children with meningitis are given maintenance plus replacement fluid therapy. J Pediatr 1991; 117:515-522
114. Ceneviva G, Paschall JA, Maffei F, et al: Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 1998; 102: e19
115. Keeley SR, Bohn DJ: The use of inotropic and afterload-reducing agents in neonates. Clin Perinatol 1988; 15:467-489
116. Roberts JD Jr, Fineman JR, Morin FC III, et al: Inhaled nitric oxide and persistent pulmonary hypertension of the new born. Inhaled Nitric Oxide Study Group. N Engl J Med 1997; 336:605-610
117. Barton P, Garcia J, Kouatli A, et al: Memodynamic effects of i. v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Chest 1996; 109:1302-1312
118. Lindsay CA, Barton P, Lawless S, et al: Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock. J Pediatr 1998; 132:329-334
119. Irazuzta JE, Pretzlaff RK, Rowin ME: Amrinone in pediatric refractory septic shock: An open-label pharmacodynamic study. Pediatr Crit Care Med 2001; 2:24-28
120. Lauterbach R, Pawlik D, Kowalczyk D, et al: Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: A placebo-controlled, double-blind trial. Crit Care Med 1999; 27:807-814
121. Carcillo JA, Fields AI, American College of Critical Care Medicine Task Force Committee Members: Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002; 30:1365-1378
122. De Kleijn ED, Joosten KF, Van Rijn B, et al: Low serum cortisol in combination with high adrenocorticotrophic hormone concentrations are associated with poor outcome in children with severe meningococcal disease. Pediatr Infect Dis J 2002; 21: 330-336
123. Riordan FA, Thomson AP, Ratcliffe JM, et al: Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: Evidence of adrenal insufficiency? Crit Care Med 1999; 27: 2257-2261
124. Min M, U T, Aye M, et al: Hydrocortisone in the management of dengue shock syndrome. Southeast Asian J Trop Med Public Health 1975; 6:573-579
125. Sumarmo, Talogo W, Asrin A, et al: Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics 1982; 69: 45-49
126. Hazelzet JA, de Kleijn ED, de Groot R: Endothelial protein C activation in meningococcal sepsis. N Engl J Med 2001; 345: 1776-1777
127. de Kleijn ED, de Groot R, Hack CE, et al: Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: A randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med 2003; 31:1839-1847
128. Bilgin K, Yaramis A, Haspolat K, et al: A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics 2001; 107:36-41
129. La Gamma EF, De Castro MH: What is the rationale for the use of granulocyte and granulocyte-macrophage colony-stimulating factors in the neonatal intensive care unit? Acta Paediatr Suppl 2002; 91: 109-116
130. Chaïbou M, Tucci M, Dugas MA, et al: Clinically significant upper gastrointestinal bleeding acquired in a pediatric intensive care unit: A prospective study. Pediatrics 1998; 102:933-938
131. Gauvin F, Dugas M, Chaïbou M, et al: The impact of clinically significant upper gastrointestinal bleeding in a pediatric intensive care unit. Pediatr Crit Care Med 2001; 2:294-298
132. Alejandria MM, Lansang MA, Dans LF, et al: Intravenous immunoglobulin for treating sepsis and septic shock. Cochrane Database Syst Rev 2002; (1):CD001090
133. Meyer DM, Jessen ME: Results of extracorporeal membrane oxygenation in children with sepsis. The Extracorporeal LifeSupport Organization. Ann Thorac Surg 1997; 63: 756-761
134. Goldman AP, Kerr SJ, Butt W, et al: Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease. Lancet 1997; 349:466-469
135. Brochard L, Rauss A, Benito S, et al: Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. Am J Respir Crit Care Med 1994; 150: 896-903